- Home
- All Stock List
- NSE
- Blue Jet Healthcare Ltd Share Price
723.25
12.10 (1.70%)
-
Outperforms Index
90.23%
Return (1Y)
Beaten Nifty 50 by 82.73%
-
More Volatile
3.38%
Standard Deviation (1Y)
Higher than Nifty 50 by 2.43%
-
Consistent Performer
8/12
Months
beaten Nifty 50
-
AxisDirect View
No View
968
348
News & Announcements
-
The broker cited a favourable outlook supported by the company's ability to scale up high-margin products and secure more long-term contracts, which could potentially enhance both growth and valuations.
The brokerage noted that Blue Jet?s advanced research and development capabilities, along with its backward integration and expertise in complex chemistries, position it well to serve both regulated and emerging markets. These factors, it said, place the company at the forefront of delivering high-value pharma solutions.
Looking ahead, the brokerage expects Blue Jet's revenue growth to be fueled by its pipeline of new products in iodinated and gadolinium contrast media, novel chemical entity (NCE) intermediates, and innovations in high-intensity sweeteners.
Blue Jet Healthcare is a specialty pharmaceutical and healthcare ingredient and intermediate company, operating under a contract development and manufacturing organization (CDMO) business model. The company has specialized chemistry capabilities in contrast media intermediates and high-intensity sweeteners.
On a standalone basis, net profit of Blue Jet Healthcare soared 208.25% to Rs 98.98 crore while net sales climbed 90.92% to Rs 318.38 crore in Q3 December 2024 over Q3 December 2023.
Powered by Capital Market - Live News
-
Blue Jet Healthcare standalone net profit rises 208.25% in the December 2024 quarter
29 - Jan - 2025 12:00 | 94 days ago
Net profit of Blue Jet Healthcare rose 208.25% to Rs 98.98 crore in the quarter ended December 2024 as against Rs 32.11 crore during the previous quarter ended December 2023. Sales rose 90.92% to Rs 318.38 crore in the quarter ended December 2024 as against Rs 166.76 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 318.38 166.76 91 OPM % 38.95 32.74 - PBDT 137.24 61.30 124 PBT 132.49 53.44 148 NP 98.98 32.11 208 Powered by Capital Market - Live News
-
Blue Jet Healthcare to table results
100 days ago
-
Blue Jet Healthcare standalone net profit rises 208.25% in the December 2024 quarter
29 - Jan - 2025 12:00 | 94 days ago
Net profit of Blue Jet Healthcare rose 208.25% to Rs 98.98 crore in the quarter ended December 2024 as against Rs 32.11 crore during the previous quarter ended December 2023. Sales rose 90.92% to Rs 318.38 crore in the quarter ended December 2024 as against Rs 166.76 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 318.38 166.76 91 OPM % 38.95 32.74 - PBDT 137.24 61.30 124 PBT 132.49 53.44 148 NP 98.98 32.11 208 Powered by Capital Market - Live News
-
Blue Jet Healthcare to table results
100 days ago
-
Blue Jet Healthcare standalone net profit rises 21.89% in the September 2024 quarter
29 - Oct - 2024 12:00 | 186 days ago
Net profit of Blue Jet Healthcare rose 21.89% to Rs 58.35 crore in the quarter ended September 2024 as against Rs 47.87 crore during the previous quarter ended September 2023. Sales rose 14.84% to Rs 208.26 crore in the quarter ended September 2024 as against Rs 181.35 crore during the previous quarter ended September 2023.
Particulars Quarter Ended Sep. 2024 Sep. 2023 % Var. Sales 208.26 181.35 15 OPM % 33.37 34.54 - PBDT 81.55 70.80 15 PBT 76.93 64.33 20 NP 58.35 47.87 22 Powered by Capital Market - Live News
-
The broker cited a favourable outlook supported by the company's ability to scale up high-margin products and secure more long-term contracts, which could potentially enhance both growth and valuations.
The brokerage noted that Blue Jet?s advanced research and development capabilities, along with its backward integration and expertise in complex chemistries, position it well to serve both regulated and emerging markets. These factors, it said, place the company at the forefront of delivering high-value pharma solutions.
Looking ahead, the brokerage expects Blue Jet's revenue growth to be fueled by its pipeline of new products in iodinated and gadolinium contrast media, novel chemical entity (NCE) intermediates, and innovations in high-intensity sweeteners.
Blue Jet Healthcare is a specialty pharmaceutical and healthcare ingredient and intermediate company, operating under a contract development and manufacturing organization (CDMO) business model. The company has specialized chemistry capabilities in contrast media intermediates and high-intensity sweeteners.
On a standalone basis, net profit of Blue Jet Healthcare soared 208.25% to Rs 98.98 crore while net sales climbed 90.92% to Rs 318.38 crore in Q3 December 2024 over Q3 December 2023.
Powered by Capital Market - Live News
-
Blue Jet Healthcare standalone net profit rises 208.25% in the December 2024 quarter
29 - Jan - 2025 12:00 | 94 days ago
Net profit of Blue Jet Healthcare rose 208.25% to Rs 98.98 crore in the quarter ended December 2024 as against Rs 32.11 crore during the previous quarter ended December 2023. Sales rose 90.92% to Rs 318.38 crore in the quarter ended December 2024 as against Rs 166.76 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 318.38 166.76 91 OPM % 38.95 32.74 - PBDT 137.24 61.30 124 PBT 132.49 53.44 148 NP 98.98 32.11 208 Powered by Capital Market - Live News
-
Blue Jet Healthcare to table results
100 days ago
-
Blue Jet Healthcare standalone net profit rises 21.89% in the September 2024 quarter
29 - Oct - 2024 12:00 | 186 days ago
Net profit of Blue Jet Healthcare rose 21.89% to Rs 58.35 crore in the quarter ended September 2024 as against Rs 47.87 crore during the previous quarter ended September 2023. Sales rose 14.84% to Rs 208.26 crore in the quarter ended September 2024 as against Rs 181.35 crore during the previous quarter ended September 2023.
Particulars Quarter Ended Sep. 2024 Sep. 2023 % Var. Sales 208.26 181.35 15 OPM % 33.37 34.54 - PBDT 81.55 70.80 15 PBT 76.93 64.33 20 NP 58.35 47.87 22 Powered by Capital Market - Live News
-
The broker cited a favourable outlook supported by the company's ability to scale up high-margin products and secure more long-term contracts, which could potentially enhance both growth and valuations.
The brokerage noted that Blue Jet?s advanced research and development capabilities, along with its backward integration and expertise in complex chemistries, position it well to serve both regulated and emerging markets. These factors, it said, place the company at the forefront of delivering high-value pharma solutions.
Looking ahead, the brokerage expects Blue Jet's revenue growth to be fueled by its pipeline of new products in iodinated and gadolinium contrast media, novel chemical entity (NCE) intermediates, and innovations in high-intensity sweeteners.
Blue Jet Healthcare is a specialty pharmaceutical and healthcare ingredient and intermediate company, operating under a contract development and manufacturing organization (CDMO) business model. The company has specialized chemistry capabilities in contrast media intermediates and high-intensity sweeteners.
On a standalone basis, net profit of Blue Jet Healthcare soared 208.25% to Rs 98.98 crore while net sales climbed 90.92% to Rs 318.38 crore in Q3 December 2024 over Q3 December 2023.
Powered by Capital Market - Live News
-
Blue Jet Healthcare standalone net profit rises 208.25% in the December 2024 quarter
29 - Jan - 2025 12:00 | 94 days ago
Net profit of Blue Jet Healthcare rose 208.25% to Rs 98.98 crore in the quarter ended December 2024 as against Rs 32.11 crore during the previous quarter ended December 2023. Sales rose 90.92% to Rs 318.38 crore in the quarter ended December 2024 as against Rs 166.76 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 318.38 166.76 91 OPM % 38.95 32.74 - PBDT 137.24 61.30 124 PBT 132.49 53.44 148 NP 98.98 32.11 208 Powered by Capital Market - Live News
-
Blue Jet Healthcare to table results
100 days ago
-
Blue Jet Healthcare standalone net profit rises 208.25% in the December 2024 quarter
29 - Jan - 2025 12:00 | 94 days ago
Net profit of Blue Jet Healthcare rose 208.25% to Rs 98.98 crore in the quarter ended December 2024 as against Rs 32.11 crore during the previous quarter ended December 2023. Sales rose 90.92% to Rs 318.38 crore in the quarter ended December 2024 as against Rs 166.76 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 318.38 166.76 91 OPM % 38.95 32.74 - PBDT 137.24 61.30 124 PBT 132.49 53.44 148 NP 98.98 32.11 208 Powered by Capital Market - Live News
-
Blue Jet Healthcare to table results
100 days ago
-
Blue Jet Healthcare standalone net profit rises 21.89% in the September 2024 quarter
29 - Oct - 2024 12:00 | 186 days ago
Net profit of Blue Jet Healthcare rose 21.89% to Rs 58.35 crore in the quarter ended September 2024 as against Rs 47.87 crore during the previous quarter ended September 2023. Sales rose 14.84% to Rs 208.26 crore in the quarter ended September 2024 as against Rs 181.35 crore during the previous quarter ended September 2023.
Particulars Quarter Ended Sep. 2024 Sep. 2023 % Var. Sales 208.26 181.35 15 OPM % 33.37 34.54 - PBDT 81.55 70.80 15 PBT 76.93 64.33 20 NP 58.35 47.87 22 Powered by Capital Market - Live News
Stock Trivia
FII shareholding in Blue Jet Healthcare Ltd has increased by 106.91% since past 3 Months
MF shareholding in Blue Jet Healthcare Ltd has decreased by -62.69% since past 1 Year
FII shareholding in Blue Jet Healthcare Ltd has increased by 106.91% since past 3 Months
MF shareholding in Blue Jet Healthcare Ltd has decreased by -48.28% since past 3 Months
FII shareholding in Blue Jet Healthcare Ltd has increased by 13.91% since past 1 Year
MF shareholding in Blue Jet Healthcare Ltd has decreased by -62.69% since past 1 Year
FII shareholding in Blue Jet Healthcare Ltd has increased by 106.91% since past 3 Months
MF shareholding in Blue Jet Healthcare Ltd has decreased by -62.69% since past 1 Year
